Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors

Cell Cycle

Volumn 14, Issue 12, 2015, Pages 1786-1798

  Bendris, Nawal ^a,b,c   Lemmers, Bénédicte ^a,b   Blanchard, Jean Marie ^a,b  

^a CNRS   (France)

^b UNIV MONTPELLIER   (France)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cytoskeleton; EMT; Invasion; Mitosis; Rho GTPases; Transcription

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1C; CYCLINE; PROTEIN P21; PROTEIN P27; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN E;

CANCER CELL; CANCER RESEARCH; CELL CYCLE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL FATE; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CYTOSKELETON; DNA DAMAGE; DNA REPAIR; DNA REPLICATION ORIGIN; HUMAN; NONHUMAN; PROTEIN FUNCTION; REVIEW; TRANSCRIPTION REGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL NUCLEUS; CYTOPLASM; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENETIC TRANSCRIPTION; GENETICS; INTERPHASE; MALE; METABOLISM; MITOSIS; MOUSE; NEOPLASM; PATHOLOGY; PHENOTYPE; TUMOR INVASION;

ANIMALS; CELL CYCLE; CELL NUCLEUS; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASES; CYCLINS; CYTOPLASM; CYTOSKELETON; DNA DAMAGE; DNA REPAIR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; INTERPHASE; MALE; MICE; MITOSIS; NEOPLASM INVASIVENESS; NEOPLASMS; PHENOTYPE; TRANSCRIPTION, GENETIC;

EID: 84943739158     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.1080/15384101.2014.998085     Document Type: Review

References (141)

1. Nigg EA. Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol 2001; 2: 21-32; PMID: 11413462; http://dx. doi. org/10. 1038/35048096.
2. Pines J. Four-dimensional control of the cell cycle. Nat Cell Biol 1999; 1: E73-9; PMID: 10559915; http://dx. doi. org/10. 1038/11041.
3. Santamaria D, Barriere C, Cerqueira S, Hunt A, Tardy C, Newton K, Caceres JF, Dubus P, Malumbres M, Barbacid M. Cdk1 is sufficient to drive the mammalian cell cycle. Nature 2007; 448: 811-5; PMID: 17700700; http://dx. doi. org/10. 1038/nature 06046.
4. Hochegger H, Takeda S, Hunt T. Cyclin-dependent kinases and cell-cycle transitions: does one fit all? Nat Rev Mol Cell Biol 2008; 9: 910-6; PMID: 18813291; http://dx. doi. org/10. 1038/nrm2510.
5. Geng Y, Yu Q, Sicinska E, Das M, Schneider JE, Bhattacharya S, Rideout WM, Bronson RT, Gardner H, Sicinski P. Cyclin E ablation in the mouse. Cell 2003; 114: 431-43; PMID: 12941272; http://dx. doi. org/10. 1016/S0092-8674(03)00645-7.
6. Kozar K, Ciemerych MA, Rebel VI, Shigematsu H, Zagozdzon A, Sicinska E, Geng Y, Yu Q, Bhattacharya S, Bronson RT, et al. Mouse development and cell proliferation in the absence of D-cyclins. Cell 2004; 118: 477-91; PMID: 15315760; http://dx. doi. org/10. 1016/j. cell. 2004. 07. 025.
7. Mendez J. Cell proliferation without cyclin E-CDK2. Cell 2003; 114: 398-9; PMID: 12941268; http://dx. doi. org/10. 1016/S0092-8674(03)00649-4.
8. Parisi T, Beck AR, Rougier N, McNeil T, Lucian L, Werb Z, Amati B. Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells. EMBO J 2003; 22: 4794-803; PMID: 12970191; http://dx. doi. org/10. 1093/emboj/cdg482.
9. Kalaszczynska I, Geng Y, Iino T, Mizuno S, Choi Y, Kondratiuk I, Silver DP, Wolgemuth DJ, Akashi K, Sicinski P. Cyclin A is redundant in fibroblasts but essential in hematopoietic and embryonic stem cells. Cell 2009; 138: 352-65; PMID: 19592082; http://dx. doi. org/10. 1016/j. cell. 2009. 04. 062.
10. Sicinska E, Aifantis I, Le L Cam, Swat W, Borowski C, Yu Q, Ferrando AA, Levin SD, Geng Y, von Boehmer H, et al. Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell 2003; 4: 451-61; PMID: 14706337; http://dx. doi. org/10. 1016/S1535-6108(03)00301-5.
11. Darbon JM, Devault A, Taviaux S, Fesquet D, Martinez AM, Galas S, Cavadore JC, Doree M, Blanchard JM. Cloning, expression and subcellular localization of the human homolog of p40MO15 catalytic subunit of cdk-activating kinase. Oncogene 1994; 9: 3127-38; PMID: 7936635.
12. Fesquet D, Labbe JC, Derancourt J, Capony JP, Galas S, Girard F, Lorca T, Shuttleworth J, Doree M, Cavadore JC. The MO15 gene encodes the catalytic subunit of a protein kinase that activates cdc2 and other cyclin-dependent kinases (CDKs) through phosphorylation of Thr161 and its homologues. EMBO J 1993; 12: 3111-21; PMID: 8344251.
13. Fisher RP, Morgan DO. A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 1994; 78: 713-24; PMID: 8069918; http://dx. doi. org/10. 1016/0092-8674(94)90535-5.
14. Poon RY, Yamashita K, Adamczewski JP, Hunt T, Shuttleworth J. The cdc2-related protein p40MO15 is the catalytic subunit of a protein kinase that can activate p33cdk2 and p34cdc2. EMBO J 1993; 12: 3123-32; PMID: 8393783.
15. Solomon MJ, Harper JW, Shuttleworth J. 1993. CAK, the p34cdc2 activating kinase, contains a protein identical or closely related to p40MO15. EMBO J. 12: 3133-42; PMID: 8344252.
16. Ganuza M, Saiz-Ladera C, Canamero M, Gomez G, Schneider R, Blasco MA, Pisano D, Paramio JM, Santamaria D, Barbacid M. Genetic inactivation of Cdk7 leads to cell cycle arrest and induces premature aging due to adult stem cell exhaustion. EMBO J 2012; 31: 2498-510; PMID: 22505032; http://dx. doi. org/10. 1038/emboj. 2012. 94.
17. Shiekhattar R, Mermelstein F, Fisher RP, Drapkin R, Dynlacht B, Wessling HC, Morgan DO, Reinberg D. Cdk-activating kinase complex is a component of human transcription factor TFIIH. Nature 1995; 374: 283-7; PMID: 7533895; http://dx. doi. org/10. 1038/374283a0.
18. Larochelle S, Amat R, Glover-Cutter K, Sanso M, Zhang C, Allen JJ, Shokat KM, Bentley DL, Fisher RP. Cyclin-dependent kinase control of the initiation-toelongation switch of RNA polymerase II. Nat Struct Mol Biol 2012; 19: 1108-15; PMID: 23064645; http://dx. doi. org/10. 1038/nsmb. 2399.
19. Egly JM, Coin F. A history of TFIIH: two decades of molecular biology on a pivotal transcription/repair factor. DNA Repair (Amst) 2011; 10: 714-21; PMID: 21592869.
20. Lolli G, Johnson LN. CAK-Cyclin-dependent Activating Kinase: a key kinase in cell cycle control and a target for drugs? Cell Cycle 2005; 4: 572-7; PMID: 15876871; http://dx. doi. org/10. 4161/cc. 4. 4. 1607.
21. Bour G, Gaillard E, Bruck N, Lalevee S, Plassat JL, Busso D, Samama JP, Rochette-Egly C. Cyclin H binding to the RARalpha activation function (AF)-2 domain directs phosphorylation of the AF-1 domain by cyclin-dependent kinase 7. Proc Natl Acad Sci U S A 2005; 102: 16608-13; PMID: 16275922; http://dx. doi. org/10. 1073/pnas. 0505556102.
22. Lee DK, Duan HO, Chang C. From androgen receptor to the general transcription factor TFIIH. Identification of cdk activating kinase (CAK) as an androgen receptor NH(2)-terminal associated coactivator. J Biol Chem 2000; 275: 9308-13; PMID: 10734072; http://dx. doi. org/10. 1074/jbc. 275. 13. 9308.
23. Rochette-Egly C, Adam S, Rossignol M, Egly JM, Chambon P. Stimulation of RAR alpha activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7. Cell 1997; 90: 97-107; PMID: 9230306; http://dx. doi. org/10. 1016/S0092-8674(00)80317-7.
24. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70; PMID: 10647931; http://dx. doi. org/10. 1016/S0092-8674(00)81683-9.
25. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-74; PMID: 21376230; http://dx. doi. org/10. 1016/j. cell. 2011. 02. 013.
26. Bortner DM, Rosenberg MP. Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol Cell Biol 1997; 17: 453-9; PMID: 8972226.
27. Karsunky H, Geisen C, Schmidt T, Haas K, Zevnik B, Gau E, Moroy T. Oncogenic potential of cyclin E in Tcell lymphomagenesis in transgenic mice: evidence for cooperation between cyclin E and Ras but not Myc. Oncogene 1999; 18: 7816-24; PMID: 10618723; http://dx. doi. org/10. 1038/sj. onc. 1203205.
28. Yu Q, Geng Y, Sicinski P. Specific protection against breast cancers by cyclin D1 ablation. Nature 2001; 411: 1017-21; PMID: 11429595; http://dx. doi. org/10. 1038/35082500.
29. Dulic V, Drullinger LF, Lees E, Reed SI, Stein GH. Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin ECdk2 and cyclin D1-Cdk2 complexes. Proc Natl Acad Sci U S A 1993; 90: 11034-8; PMID: 8248208; http://dx. doi. org/10. 1073/pnas. 90. 23. 11034.
30. Lucibello FC, Sewing A, Brusselbach S, Burger C, Muller R. Deregulation of cyclins D1 and E and suppression of cdk2 and cdk4 in senescent human fibroblasts. J Cell Sci 1993; 105 (Pt 1): 123-33; PMID: 8360268.
31. Leontieva OV, Blagosklonny MV. CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: duration of cell cycle arrest and MTOR activity determine geroconversion. Cell Cycle 2013; 12: 3063-9; PMID: 23974099; http://dx. doi. org/10. 4161/cc. 26130.
32. Leontieva OV, Natarajan V, Demidenko ZN, Burdelya LG, Gudkov AV, Blagosklonny MV. Hypoxia suppresses conversion from proliferative arrest to cellular senescence. Proc Natl Acad Sci U S A 2012; 109: 13314-8; PMID: 22847439; http://dx. doi. org/10. 1073/pnas. 1205690109.
33. Haas K, Johannes C, Geisen C, Schmidt T, Karsunky H, Blass-Kampmann S, Obe G, Moroy T. Malignant transformation by cyclin E and Ha-Ras correlates with lower sensitivity towards induction of cell death but requires functional Myc and CDK4. Oncogene 1997; 15: 2615-23; PMID: 9399649; http://dx. doi. org/10. 1038/sj. onc. 1201434.
34. Geisen C, Moroy T. The oncogenic activity of cyclin E is not confined to Cdk2 activation alone but relies on several other, distinct functions of the protein. J Biol Chem 2002; 277: 39909-18; PMID: 12149264; http://dx. doi. org/10. 1074/jbc. M205919200.
35. Geng Y, Lee YM, Welcker M, Swanger J, Zagozdzon A, Winer JD, Roberts JM, Kaldis P, Clurman BE, Sicinski P. Kinase-independent function of cyclin E. Mol Cell 2007; 25: 127-39; PMID: 17218276; http://dx. doi. org/10. 1016/j. molcel. 2006. 11. 029.
36. Geng Y, Sicinski P. Differences in regulation and function of E-cyclins in human cancer cells. Cell Cycle 2013; 12: 1165; PMID: 23549169; http://dx. doi. org/10. 4161/cc. 24487.
37. Coverley D, Laman H, Laskey RA. Distinct roles for cyclins E and A during DNA replication complex assembly and activation. Nat Cell Biol 2002; 4: 523-8; PMID: 12080347; http://dx. doi. org/10. 1038/ncb813.
38. Ferguson RL, Maller JL. Centrosomal localization of cyclin E-Cdk2 is required for initiation of DNA synthesis. Curr Biol 2010; 20: 856-60; PMID: 20399658; http://dx. doi. org/10. 1016/j. cub. 2010. 03. 028.
39. Ferguson RL, Pascreau G, Maller JL. The cyclin A centrosomal localization sequence recruits MCM5 and Orc1 to regulate centrosome reduplication. J Cell Sci 2010; 123: 2743-9; PMID: 20663915; http://dx. doi. org/10. 1242/jcs. 073098.
40. Hemerly AS, Prasanth SG, Siddiqui K, Stillman B. Orc1 controls centriole and centrosome copy number in human cells. Science 2009; 323: 789-93; PMID: 19197067; http://dx. doi. org/10. 1126/science. 1166745.
41. Berger C, Pallavi SK, Prasad M, Shashidhara LS, Technau GM. Cyclin E acts under the control of Hox-genes as a cell fate determinant in the developing central nervous system. Cell Cycle 2005; 4: 422-5; PMID: 15684605; http://dx. doi. org/10. 4161/cc. 4. 3. 1524.
42. Berger C, Kannan R, Myneni S, Renner S, Shashidhara LS, Technau GM. Cell cycle independent role of Cyclin E during neural cell fate specification in Drosophila is mediated by its regulation of Prospero function. Dev Biol 2010; 337: 415-24; PMID: 19914234; http://dx. doi. org/10. 1016/j. ydbio. 2009. 11. 012.
43. Odajima J, Wills ZP, Ndassa YM, Terunuma M, Kretschmannova K, Deeb TZ, Geng Y, Gawrzak S, Quadros IM, Newman J, et al. Cyclin E constrains Cdk5 activity to regulate synaptic plasticity and memory formation. Dev Cell 2011; 21: 655-68; PMID: 21944720; http://dx. doi. org/10. 1016/j. devcel. 2011. 08. 009.
44. Rogulja D, Young MW. Control of sleep by cyclin A and its regulator. Science 2012; 335: 1617-21.
45. Coqueret O. Linking cyclins to transcriptional control. Gene 2002; 299: 35-55; PMID: 12459251; http://dx. doi. org/10. 1016/S0378-1119(02)01055-7.
46. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. Minireview: Cyclin D1: normal and abnormal functions. Endocrinology 2004; 145: 5439-47; PMID: 15331580; http://dx. doi. org/10. 1210/en. 2004-0959.
47. Fantl V, Stamp G, Andrews A, Rosewell I, Dickson C. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev 1995; 9: 2364-72; PMID: 7557388; http://dx. doi. org/10. 1101/gad. 9. 19. 2364.
48. Rane SG, Dubus P, Mettus RV, Galbreath EJ, Boden G, Reddy EP, Barbacid M. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat Genet 1999; 22: 44-52; PMID: 10319860; http://dx. doi. org/10. 1038/8751.
49. Knudsen KE, Diehl JA, Haiman CA, Knudsen ES. Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 2006; 25: 1620-8; PMID: 16550162; http://dx. doi. org/10. 1038/sj. onc. 1209371.
50. Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder WD, Heighway J. Alternate splicing produces a novel cyclin D1 transcript. Oncogene 1995; 11: 1005-11; PMID: 7675441.
51. Li Z, Wang C, Jiao X, Lu Y, Fu M, Quong AA, Dye C, Yang J, Dai M, Ju X, et al. Cyclin D1 regulates cellular migration through the inhibition of thrombospondin 1 and ROCK signaling. Mol Cell Biol 2006b; 26: 4240-56; http://dx. doi. org/10. 1128/MCB. 02124-05.
52. Zhong Z, Yeow WS, Zou C, Wassell R, Wang C, Pestell RG, Quong JN, Quong AA. Cyclin D1/cyclindependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells. Cancer Res 70: 2105-14; PMID: 20179208; http://dx. doi. org/10. 1158/0008-5472. CAN-08-1108.
53. Sakamaki T, Casimiro MC, Ju X, Quong AA, Katiyar S, Liu M, Jiao X, Li A, Zhang X, Lu Y, et al. Cyclin D1 determines mitochondrial function in vivo. Mol Cell Biol 2006; 26: 5449-69; PMID: 16809779; http://dx. doi. org/10. 1128/MCB. 02074-05.
54. Wang C, Li Z, Lu Y, Du R, Katiyar S, Yang J, Fu M, Leader JE, Quong A, Novikoff PM, Pestell RG. Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function. Proc Natl Acad Sci U S A 2006; 103: 11567-72; PMID: 16864783; http://dx. doi. org/10. 1073/pnas. 0603363103.
55. Lamb J, Ramaswamy S, Ford HL, Contreras B, Martinez RV, Kittrell FS, Zahnow CA, Patterson N, Golub TR, Ewen ME. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 2003; 114: 323-34; PMID: 12914697; http://dx. doi. org/10. 1016/S0092-8674(03)00570-1.
56. McMahon C, Suthiphongchai T, DiRenzo J, Ewen ME. P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor. Proc Natl Acad Sci U S A 1999; 96: 5382-7; PMID: 10318892; http://dx. doi. org/10. 1073/pnas. 96. 10. 5382.
57. Zwijsen RM, Wientjens E, Klompmaker R, van der Sman J, Bernards R, Michalides RJ. CDK-independent activation of estrogen receptor by cyclin D1. Cell 1997; 88: 405-15; PMID: 9039267; http://dx. doi. org/10. 1016/S0092-8674(00)81879-6.
58. Comstock CE, Augello MA, Schiewer MJ, Karch J, Burd CJ, Ertel A, Knudsen ES, Jessen WJ, Aronow BJ, Knudsen KE. Cyclin D1 is a selective modifier of androgen-dependent signaling and androgen receptor function. J Biol Chem 2011; 286: 8117-27; PMID: 21212260; http://dx. doi. org/10. 1074/jbc. M110. 170720.
59. Knudsen KE, Cavenee WK, Arden KC. D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability. Cancer Res 1999; 59: 2297-301; PMID: 10344732.
60. Ratineau C, Petry MW, Mutoh H, Leiter AB. Cyclin D1 represses the basic helix-loop-helix transcription factor, BETA2/NeuroD. J Biol Chem 2002; 277: 8847-53; PMID: 11788592; http://dx. doi. org/10. 1074/jbc. M110747200.
61. Bienvenu F, Gascan H, Coqueret O. Cyclin D1 represses STAT3 activation through a Cdk4-independent mechanism. J Biol Chem 2001; 276: 16840-7; PMID: 11279133; http://dx. doi. org/10. 1074/jbc. M100795200.
62. Wang C, Pattabiraman N, Zhou JN, Fu M, Sakamaki T, Albanese C, Li Z, Wu K, Hulit J, Neumeister P, et al. Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation. Mol Cell Biol 2003; 23: 6159-73; PMID: 12917338; http://dx. doi. org/10. 1128/MCB. 23. 17. 6159-6173. 2003.
63. Knudsen KE. Cyclin D1 goes metabolic: dual functions of cyclin D1 in regulating lipogenesis. Cell Cycle 2012; 11: 3533-4; PMID: 22951541; http://dx. doi. org/10. 4161/cc. 22039.
64. Casimiro MC, Crosariol M, Loro E, Ertel A, Yu Z, Dampier W, Saria EA, Papanikolaou A, Stanek TJ, Li Z, et al. ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice. J Clin Invest 2012; 122: 833-43; PMID: 22307325; http://dx. doi. org/10. 1172/JCI60256.
65. Bienvenu F, Jirawatnotai S, Elias JE, Meyer CA, Mizeracka K, Marson A, Frampton GM, Cole MF, Odom DT, Odajima J, et al. Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen. Nature 2010; 463: 374-8; PMID: 20090754; http://dx. doi. org/10. 1038/nature08684.
66. Jin RJ, Lho Y, Wang Y, Ao M, Revelo MP, Hayward SW, Wills ML, Logan SK, Zhang P, Matusik RJ. Down-regulation of p57Kip2 induces prostate cancer in the mouse. Cancer Res 2008; 68: 3601-8; PMID: 18483241; http://dx. doi. org/10. 1158/0008-5472. CAN-08-0073.
67. Li Z, Jiao X, Wang C, Shirley LA, Elsaleh H, Dahl O, Wang M, Soutoglou E, Knudsen ES, Pestell RG. Alternative cyclin D1 splice forms differentially regulate the DNA damage response. Cancer Res 2010; 70: 8802-11; PMID: 20940395; http://dx. doi. org/10. 1158/0008-5472. CAN-10-0312.
68. Manes T, Zheng DQ, Tognin S, Woodard AS, Marchisio PC, Languino LR. Alpha(v)beta3 integrin expression up-regulates cdc2, which modulates cell migration. J Cell Biol 2003; 161: 817-26; PMID: 12771130; http://dx. doi. org/10. 1083/jcb. 200212172.
69. Song Y, Zhao C, Dong L, Fu M, Xue L, Huang Z, Tong T, Zhou Z, Chen A, Yang Z, Lu N, Zhan Q. Overexpression of cyclin B1 in human esophageal squamous cell carcinoma cells induces tumor cell invasive growth and metastasis. Carcinogenesis 2008; 29: 307-15; PMID: 18048386; http://dx. doi. org/10. 1093/carcin/bgm269.
70. Blethrow JD, Glavy JS, Morgan DO, Shokat KM. Covalent capture of kinase-specific phosphopeptides reveals Cdk1-cyclin B substrates. Proc Natl Acad Sci U S A 2008; 105: 1442-7; PMID: 18234856; http://dx. doi. org/10. 1073/pnas. 0708966105.
71. Chi Y, Welcker M, Hizli AA, Posakony JJ, Aebersold R, Clurman BE. Identification of CDK2 substrates in human cell lysates. Genome Biol 2008; 9: R149.
72. Hirota T, Morisaki T, Nishiyama Y, Marumoto T, Tada K, Hara T, Masuko N, Inagaki M, Hatakeyama K, Saya H. Zyxin, a regulator of actin filament assembly, targets the mitotic apparatus by interacting with h-warts/LATS1 tumor suppressor. J Cell Biol 2000; 149: 1073-86; PMID: 10831611; http://dx. doi. org/10. 1083/jcb. 149. 5. 1073.
73. Burridge K, Wennerberg K. Rho and Rac take center stage. Cell 2004; 116: 167-79; PMID: 14744429; http://dx. doi. org/10. 1016/S0092-8674(04)00003-0.
74. Jaffe AB, Hall A. Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 2005; 21: 247-69; PMID: 16212495; http://dx. doi. org/10. 1146/annurev. cellbio. 21. 020604. 150721.
75. Hall A. Rho GTPases and the control of cell behaviour. Biochem Soc Trans 2005; 33: 891-5; PMID: 16246005; http://dx. doi. org/10. 1042/BST20050891.
76. Heasman SJ, Ridley AJ. Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat Rev Mol Cell Biol 2008; 9: 690-701; PMID: 18719708; http://dx. doi. org/10. 1038/nrm2476.
77. Karlsson R, Pedersen ED, Wang Z, Brakebusch C. Rho GTPase function in tumorigenesis. Biochim Biophys Acta 2009; 1796: 91-8; PMID: 19327386.
78. Raftopoulou M, Hall A. Cell migration: Rho GTPases lead the way. Dev Biol 2004; 265: 23-32; PMID: 14697350; http://dx. doi. org/10. 1016/j. ydbio. 2003. 06. 003.
79. Mettouchi A, Klein S, Guo W, Lopez-Lago M, Lemichez E, Westwick JK, Giancotti FG. Integrin-specific activation of Rac controls progression through the G (1) phase of the cell cycle. Mol Cell 2001; 8: 115-27; PMID: 11511365; http://dx. doi. org/10. 1016/S1097-2765(01)00285-4.
80. Roovers K, Assoian RK. Effects of rho kinase and actin stress fibers on sustained extracellular signal-regulated kinase activity and activation of G(1) phase cyclin-dependent kinases. Mol Cell Biol 2003; 23: 4283-94; PMID: 12773570; http://dx. doi. org/10. 1128/MCB. 23. 12. 4283-4294. 2003.
81. Roovers K, Klein EA, Castagnino P, Assoian RK. Nuclear translocation of LIM kinase mediates Rho-Rho kinase regulation of cyclin D1 expression. Dev Cell 2003; 5: 273-84; PMID: 12919678; http://dx. doi. org/10. 1016/S1534-5807(03)00206-5.
82. Welsh CF, Roovers K, Villanueva J, Liu Y, Schwartz MA, Assoian RK. Timing of cyclin D1 expression within G1 phase is controlled by Rho. Nat Cell Biol 2001; 3: 950-7; PMID: 11715015; http://dx. doi. org/10. 1038/ncb1101-950.
83. Philips A, Roux P, Coulon V, Bellanger JM, Vie A, Vignais ML, Blanchard JM. Differential effect of Rac and Cdc42 on p38 kinase activity and cell cycle progression of nonadherent primary mouse fibroblasts. J Biol Chem 2000; 275: 5911-7; PMID: 10681583; http://dx. doi. org/10. 1074/jbc. 275. 8. 5911.
84. Besson A, Assoian RK, Roberts JM. Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors? Nat Rev Cancer 2004a; 4: 948-55; http://dx. doi. org/10. 1038/nrc1501.
85. Shimada Y, Gulli MP, Peter M. Nuclear sequestration of the exchange factor Cdc24 by Far1 regulates cell polarity during yeast mating. Nat Cell Biol 2000; 2: 117-24; PMID: 10655592; http://dx. doi. org/10. 1038/35000073.
86. Yokoo T, Toyoshima H, Miura M, Wang Y, Iida KT, Suzuki H, Sone H, Shimano H, Gotoda T, Nishimori S, et al. p57Kip2 regulates actin dynamics by binding and translocating LIM-kinase 1 to the nucleus. J Biol Chem 2003; 278: 52919-23; PMID: 14530263; http://dx. doi. org/10. 1074/jbc. M309334200.
87. Besson A, Gurian-West M, Schmidt A, Hall A, Roberts JM. p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 2004b; 18: 862-76; http://dx. doi. org/10. 1101/gad. 1185504.
88. Lee S, Helfman DM. Cytoplasmic p21Cip1 is involved in Ras-induced inhibition of the ROCK/LIMK/cofilin pathway. J Biol Chem 2004; 279: 1885-91; PMID: 14559914; http://dx. doi. org/10. 1074/jbc. M306968200.
89. Tanaka H, Yamashita T, Asada M, Mizutani S, Yoshikawa H, Tohyama M. Cytoplasmic p21(Cip1/WAF1) regulates neurite remodeling by inhibiting Rho-kinase activity. J Cell Biol 2002; 158: 321-9; PMID: 12119358; http://dx. doi. org/10. 1083/jcb. 200202071.
90. Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 2001; 3: 245-52; PMID: 11231573; http://dx. doi. org/10. 1038/35060032.
91. Tanaka H, Yamashita T, Yachi K, Fujiwara T, Yoshikawa H, Tohyama M. Cytoplasmic p21(Cip1/WAF1) enhances axonal regeneration and functional recovery after spinal cord injury in rats. Neuroscience 2004; 127: 155-64; PMID: 15219678; http://dx. doi. org/10. 1016/j. neuroscience. 2004. 05. 010.
92. Besson A, Dowdy SF, Roberts JM. CDK inhibitors: cell cycle regulators and beyond. Dev Cell 2008; 14: 159-69; PMID: 18267085; http://dx. doi. org/10. 1016/j. devcel. 2008. 01. 013.
93. Guo H, Tian T, Nan K, Wang W. p57: A multifunctional protein in cancer (Review). Int J Oncol 2010; 36: 1321-9; PMID: 20428755; http://dx. doi. org/10. 3892/ijo_00000536.
94. Vlachos P, Joseph B. The Cdk inhibitor p57(Kip2) controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics. Oncogene 2009; 28: 4175-88; PMID: 19734939; http://dx. doi. org/10. 1038/onc. 2009. 269.
95. Guo H, Lv Y, Tian T, Hu TH, Wang WJ, Sui X, Jiang L, Ruan ZP, Nan KJ. Downregulation of p57 accelerates the growth and invasion of hepatocellular carcinoma. Carcinogenesis 2011; 32: 1897-904; PMID: 22002319; http://dx. doi. org/10. 1093/carcin/bgr220.
96. Sakai K, Peraud A, Mainprize T, Nakayama J, Tsugu A, Hongo K, Kobayashi S, Rutka JT. Inducible expression of p57KIP2 inhibits glioma cell motility and invasion. J Neurooncol 2004; 68: 217-23; PMID: 15332324; http://dx. doi. org/10. 1023/B: NEON. 0000033380. 08940. c8.
97. Itoh Y, Masuyama N, Nakayama K, Nakayama KI, Gotoh Y. The cyclin-dependent kinase inhibitors p57 and p27 regulate neuronal migration in the developing mouse neocortex. J Biol Chem 2007; 282: 390-6; PMID: 17092932; http://dx. doi. org/10. 1074/jbc. M609944200.
98. Assoian RK. Stopping and going with p27kip1. Dev Cell 2004; 6: 458-9; PMID: 15068785; http://dx. doi. org/10. 1016/S1534-5807(04)00103-0.
99. Larrea MD, Wander SA, Slingerland JM. p27 as Jekyll and Hyde: regulation of cell cycle and cell motility. Cell Cycle 2009b; 8: 3455-61; http://dx. doi. org/10. 4161/cc. 8. 21. 9789.
100. Kawauchi T, Chihama K, Nabeshima Y, Hoshino M. Cdk5 phosphorylates and stabilizes p27kip1 contributing to actin organization and cortical neuronal migration. Nat Cell Biol 2006; 8: 17-26; PMID: 16341208; http://dx. doi. org/10. 1038/ncb1338.
101. Larrea MD, Hong F, Wander SA, da Silva TG, Helfman D, Lannigan D, Smith JA, Slingerland JM. RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility. Proc Natl Acad Sci U S A 2009a; 106: 9268-73; http://dx. doi. org/10. 1073/pnas. 0805057106.
102. Denicourt C, Saenz CC, Datnow B, Cui XS, Dowdy SF. Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma. Cancer Res 2007; 67: 9238-43; PMID: 17909030; http://dx. doi. org/10. 1158/0008-5472. CAN-07-1375.
103. McAllister SS, Becker-Hapak M, Pintucci G, Pagano M, Dowdy SF. Novel p27(kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions. Mol Cell Biol 2003; 23: 216-28; PMID: 12482975; http://dx. doi. org/10. 1128/MCB. 23. 1. 216-228. 2003.
104. Nagahara H, Vocero-Akbani AM, Snyder EL, Ho A, Latham DG, Lissy NA, Becker-Hapak M, Ezhevsky SA, Dowdy SF. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med 1998; 4: 1449-52; PMID: 9846587; http://dx. doi. org/10. 1038/4042.
105. Wu FY, Wang SE, Sanders ME, Shin I, Rojo F, Baselga J, Arteaga CL. Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, tumorigenicity. Cancer Res 2006; 66: 2162-72; PMID: 16489017; http://dx. doi. org/10. 1158/0008-5472. CAN-05-3304.
106. Baldassarre G, Belletti B, Nicoloso MS, Schiappacassi M, Vecchione A, Spessotto P, Morrione A, Canzonieri V, Colombatti A. p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion. Cancer Cell 2005; 7: 51-63; PMID: 15652749; http://dx. doi. org/10. 1016/j. ccr. 2004. 11. 025.
107. Diez-Juan A, Andres V. Coordinate control of proliferation and migration by the p27Kip1/cyclin-dependent kinase/retinoblastoma pathway in vascular smooth muscle cells and fibroblasts. Circ Res 2003; 92: 402-10; PMID: 12600894; http://dx. doi. org/10. 1161/01. RES. 0000059306. 71961. ED.
108. Goukassian D, Diez-Juan A, Asahara T, Schratzberger P, Silver M, Murayama T, Isner JM, Andres V. Overexpression of p27(Kip1) by doxycycline-regulated adenoviral vectors inhibits endothelial cell proliferation and migration and impairs angiogenesis. FASEB J 2001; 15: 1877-85; PMID: 11532967; http://dx. doi. org/10. 1096/fj. 01-0065com.
109. Sun J, Marx SO, Chen HJ, Poon M, Marks AR, Rabbani LE. Role for p27(Kip1) in Vascular Smooth Muscle Cell Migration. Circulation 2001; 103: 2967-72; PMID: 11413088; http://dx. doi. org/10. 1161/01. CIR. 103. 24. 2967.
110. Neumeister P, Pixley FJ, Xiong Y, Xie H, Wu K, Ashton A, Cammer M, Chan A, Symons M, Stanley ER, et al. Cyclin D1 governs adhesion and motility of macrophages. Mol Biol Cell 2003; 14: 2005-15; PMID: 12802071; http://dx. doi. org/10. 1091/mbc. 02-07-0102.
111. Matsushime H. Macrophage cell cycle control by MCSF/CSF-1. Rinsho Ketsueki 1995; 36: 406-9; PMID: 7783343.
112. Drobnjak M, Osman I, Scher HI, Fazzari M, Cordon-Cardo C. Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone. Clin Cancer Res 2000; 6: 1891-5; PMID: 10815912.
113. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J, Livingston DM. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 1993; 73: 487-97; PMID: 8343202; http://dx. doi. org/10. 1016/0092-8674(93)90136-E.
114. Li Z, Wang C, Jiao X, Katiyar S, Casimiro MC, Prendergast GC, Powell MJ, Pestell RG. Alternate cyclin D1 mRNA splicing modulates p27KIP1 binding and cell migration. J Biol Chem 2008; 283: 7007-15; PMID: 18180298; http://dx. doi. org/10. 1074/jbc. M706992200.
115. Li Z, Wang C, Prendergast GC, Pestell RG. Cyclin D1 functions in cell migration. Cell Cycle 2006c; 5: 2440-2; http://dx. doi. org/10. 4161/cc. 5. 21. 3428.
116. Pestell RG. New roles of cyclin D1. Am J Pathol 2013; 183: 3-9; PMID: 23790801; http://dx. doi. org/10. 1016/j. ajpath. 2013. 03. 001.
117. Li Z, Jiao X, Wang C, Ju X, Lu Y, Yuan L, Lisanti MP, Katiyar S, Pestell RG. Cyclin D1 induction of cellular migration requires p27(KIP1). Cancer Res 2006a; 66: 9986-94; http://dx. doi. org/10. 1158/0008-5472. CAN-06-1596.
118. Arsic N, Bendris N, Peter M, Begon-Pescia C, Rebouissou C, Gadea G, Bouquier N, Bibeau F, Lemmers B, Blanchard JM. A novel function for Cyclin A2: control of cell invasion via RhoA signaling. J Cell Biol 2012; 196: 147-62; PMID: 22232705; http://dx. doi. org/10. 1083/jcb. 201102085.
119. Bendris N, Arsic N, Lemmers B, Blanchard JM. Cyclin A2, Rho GTPases and EMT. Small GTPases 2012; 3: 225-8; PMID: 22735340; http://dx. doi. org/10. 4161/sgtp. 20791.
120. Jackman M, Kubota Y, den Elzen N, Hagting A, Pines J. Cyclin A-and cyclin E-Cdk complexes shuttle between the nucleus and the cytoplasm. Mol Biol Cell 2002; 13: 1030-45; PMID: 11907280; http://dx. doi. org/10. 1091/mbc. 01-07-0361.
121. Bendris N, Lemmers B, Blanchard JM, Arsic N. Cyclin A2 mutagenesis analysis: a new insight into CDK activation and cellular localization requirements. PLoS One 2011; 6: e22879.
122. Sanchez-Beato M, Camacho FI, Martinez-Montero JC, Saez AI, Villuendas R, Sanchez-Verde L, Garcia JF, Piris MA. Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells. Blood 1999; 94: 765-72; PMID: 10397744.
123. Bouchard C, Thieke K, Maier A, Saffrich R, Hanley-Hyde J, Ansorge W, Reed S, Sicinski P, Bartek J, Eilers M. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. EMBO J 1999; 18: 5321-33; PMID: 10508165; http://dx. doi. org/10. 1093/emboj/18. 19. 5321.
124. Perez-Roger I, Kim SH, Griffiths B, Sewing A, Land H. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1). EMBO J 1999; 18: 5310-20; PMID: 10508164; http://dx. doi. org/10. 1093/emboj/18. 19. 5310.
125. Wang YF, Chen JY, Chang SY, Chiu JH, Li WY, Chu PY, Tai SK, Wang LS. Nm23-H1 expression of metastatic tumors in the lymph nodes is a prognostic indicator of oral squamous cell carcinoma. Int J Cancer 2008; 122: 377-86; PMID: 17918157.
126. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-54; PMID: 12189386; http://dx. doi. org/10. 1038/nrc822.
127. Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumormetastasis. Dev Cell 2008; 14: 818-29; PMID: 18539112; http://dx. doi. org/10. 1016/j. devcel. 2008. 05. 009.
128. Thiery JP, Lim CT. Tumor dissemination: an EMT affair. Cancer Cell 2013; 23: 272-3; PMID: 23518345; http://dx. doi. org/10. 1016/j. ccr. 2013. 03. 004.
129. Bendris N, Cheung CT, Leong HS, Lewis JD, Chambers AF, Blanchard JM, Lemmers B. Cyclin A2, a novel regulator of EMT. Cell Mol Life Sci; 2014; PMID: 24879294.
130. Bellovin DI, Simpson KJ, Danilov T, Maynard E, RimmDL, Oettgen P, MercurioAM. Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma. Oncogene 2006; 25: 6959-67; PMID: 16715134; http://dx. doi. org/10. 1038/sj. onc. 1209682.
131. Sahai E, Marshall CJ. RHO-GTPases and cancer. Nat Rev Cancer 2002; 2: 133-42; PMID: 12635176; http://dx. doi. org/10. 1038/nrc725.
132. Hakem A, Sanchez-Sweatman O, You-Ten A, Duncan G, Wakeham A, Khokha R, Mak TW. RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis. Genes Dev 2005; 19: 1974-9; PMID: 16107613; http://dx. doi. org/10. 1101/gad. 1310805.
133. Anastasiadis PZ, Moon SY, Thoreson MA, Mariner DJ, Crawford HC, Zheng Y, Reynolds AB. Inhibition of RhoA by p120 catenin. Nat Cell Biol 2000; 2: 637-44; PMID: 10980705; http://dx. doi. org/10. 1038/35023588.
134. Grosheva I, Shtutman M, Elbaum M, Bershadsky AD. p120 catenin affects cell motility via modulation of activity of Rho-family GTPases: a link between cell-cell contact formation and regulation of cell locomotion. J Cell Sci 2001; 114: 695-707; PMID: 11171375.
135. Loukil A, Zonca M, Rebouissou C, Baldin V, Coux O, Biard-Piechaczyk M, Blanchard JM, Peter M. High-resolution live-cell imaging reveals novel cyclin A2 degradation foci involving autophagy. J Cell Sci 2014; 127: 2145-50; PMID: 24634511; http://dx. doi. org/10. 1242/jcs. 139188.
136. Barger JF, Plas DR. Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis. Endocr Relat Cancer 2010; 17: R287-304; PMID: 20699334; http://dx. doi. org/10. 1677/ERC-10-0106.
137. Dang CV. Links between metabolism and cancer. Genes Dev 2012; 26: 877-90; PMID: 22549953; http://dx. doi. org/10. 1101/gad. 189365. 112.
138. DeBerardinis RJ, Thompson CB. Cellular metabolism and disease: what do metabolic outliers teach us? Cell 2012; 148: 1132-44; PMID: 22424225; http://dx. doi. org/10. 1016/j. cell. 2012. 02. 032.
139. Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 2012; 21: 297-308; PMID: 22439925; http://dx. doi. org/10. 1016/j. ccr. 2012. 02. 014.
140. Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer 2006; 6: 449-58; PMID: 16723991; http://dx. doi. org/10. 1038/nrc1886.
141. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7: 131-42; PMID: 16493418; http://dx. doi. org/10. 1038/nrm1835.